Serono S.A. (ADR) (Public, NYSE:SRA) Germany's Merck gets US antitrust nod for Serono
WASHINGTON, Oct 31 (Reuters) - U.S. antitrust authorities have approved German drugmaker Merck KGaA's (MRCG.DE: Quote, Profile, Research) takeover of biotech firm Serono SA (SEO.VX: Quote, Profile, Research), the U.S. Federal Trade Commission said in a notice on Tuesday. U.S. officials closed their review of the transaction without taking any action to block it, the agency said. More here: http://today.reuters.com/news/articleinvesting.aspx?view=CN&storyID=2006-10-31T163849Z_01_N31198577_RTRIDST_0_HEALTH-SERONO-ANTITRUST.XML&rpc=66&type=qcna Serono posts near 20 pct increase in third quarter net profit The Swiss biotechnology and pharmaceuticals company Serono reported third quarter net income of 170.6 million dollars (136.1 million euros) for the third quarter, a 19.8 percent increase over the same period last year. Total revenue in the third quarter rose 9.5 percent over the same period last year to 699.1 million dollars, the company said in a statement. Sales of Serono's flagship multiple sclerosis drug Rebif totalling 374.8 million dollars accounted for more than half of the Swiss company's revenues. http://tech.groups.yahoo.com/group/biotech-news/ http://www.arizonabiotech.com/ http://famouspeople.wordpress.com/ http://www.arizonabiotech.com/ http://groups.yahoo.com/group/biotech-news/ http://www.arizonaentrepreneurs.com/ http://www.azhttp.com/ Yahoo! Groups Links <*> To visit your group on the web, go to: http://groups.yahoo.com/group/biotech-news/ <*> Your email settings: Individual Email | Traditional <*> To change settings online go to: http://groups.yahoo.com/group/biotech-news/join (Yahoo! ID required) <*> To change settings via email: mailto:[EMAIL PROTECTED] mailto:[EMAIL PROTECTED] <*> To unsubscribe from this group, send an email to: [EMAIL PROTECTED] <*> Your use of Yahoo! Groups is subject to: http://docs.yahoo.com/info/terms/
